A major new study reveals that older adults with cancer and type 2 diabetes who take GLP-1 receptor agonist medications (GLP-1RAs) experience significantly better overall survival rates compared to ...
In teens with a diagnosis of obesity, glucagon-like peptide-1 (GLP-1) receptor agonists may lower the risk of suicidal ideation or attempts, a retrospective cohort study suggests. Compared with those ...
Drugs like Ozempic and Wegovy were already off to fast starts because of their ability to help treat Type 2 diabetes and improve weight loss for millions of Americans. But a new study suggests that ...
A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published in Neurology. Subscribe to ...
n = number of patients included in each study group for HbA1c and body weight efficacy assessments Abbreviations: EOS: End of Study (week 16); Wk: week; BID: twice daily; CBD: cannabidiol; QD: once ...
LifeVantage announces improved results from its MindBody GLP-1 System clinical trials, showing over 200% average increase in GLP-1. LifeVantage Corporation has revealed promising new results from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback